Objective: To explore the correlation between combined detection of CD56, TPO, p63 and CK19 and clinicopathologic parameter in papillary thyroid carcinoma. Methods: one hundred patients with PTC were detected by immunohistochemistry for the expression of the CD56, TPO, p63 and CK19, and the Chi-square test was utilized to statistical analyze the relation between the above markers and clinicopathologic parameter (gender, age, number, size, location, capsule invasion, lymph node metastasis, histologic subtype of lesion). Results: The expression positive rate of CD56, TPO, p63 and CK19 was 11%, 5%, 17%, 87% respectively in 100 cases of PTC. No correlation between four markers and the clinicopathologic parameters (gender, age, number, size, location, lymph node metastasis, histologic subtype of lesion), there was no statistically significant difference (P>0.05), but the expression of CD56 in cases with capsule invasion was significantly lower than without capsule invasion, the difference was statistically significant (P<0.05), there was no correlation between expression of the other three markers and capsule invasion, the difference was not statistically significant (P>0.05). Conclusion: There is correlation between the expression of CD56 and capsule invasion, the expression of CD56 in cases with capsule invasion was significantly lower than without capsule invasion, and the low expression can predict the poor prognosis in PTC.